
Good morning, everyone. Damian Garde here, filling in for Ed Silverman once more in the waning days of the year, when out-of-office replies start to outnumber actionable emails and the workplace powers-that-be avert their eyes from just over your shoulder. Perhaps you’re using this time among the working few to chip away at long-delayed projects. Maybe you’re just passing the hours with the seemingly endless updates on a certain jailhouse romance. Either way, here as usual is a menu of tidbits to get your day rolling.
The European Union cleared Pfizer (PFE) and BioNTech’s (BNTX) Covid-19 vaccine and expects to start distributing it after Christmas, the Guardian tells us. The authorization is Europe’s first for a Covid-19 vaccine, and Pfizer said it’s prepared to immediately ship doses to the 27 member states from manufacturing sites in Germany and Belgium. Moderna’s (MRNA) vaccine is expected to receive the same clearance in early January.
Americans are increasingly willing to get immediately vaccinated for Covid-19, according to a new USA Today survey, which found that 46% of respondents said they’ll take the vaccine as soon as they can. That’s a considerable improvement over the results from a similar survey in later October, in which just 26% said they’d get vaccinated as soon as possible. In the latest survey, 32% said they would wait until others had been vaccinated before signing up, and 20% said they wouldn’t take the shot.